QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Scripts who wrote (1074)	10/11/2000 11:17:02 AM
From: Ian@SI	of 1321

Ed, QLT is doing its part. VisuDyne sales are growing ahead of guidance. Patience. Sooner or later the market will catch up with the story. Paul Sagawa of Sanford Bernstein did his survey of 60 global telcos; then reiterated LU as a strong buy while downgrading NT and CSCO. While NT and CSCO prices have been temporarily trashed, he is flat out wrong on LU which has fallen from the 70s to the very low 20s and is in danger of going to $10 near its book value. Paul Sagawa with his indepth research and his "comprehensive" survey has been flat out WRONG! QLT has taken a temporary hit as a result of equally shoddy thinking by an equally brain dead analyst from a no name house. I guess it's his job. Everyone has to earn a living. Even if they lack the competence to perform their chosen profession adequately. In time, the market will figure this out too. FWIW, Ian.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next